Gemcitabine With or Without Dalteparin in Treating Patients With Unresectable or Metastatic Pancreatic Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Kishan J. Pandya, MD
University of Rochester
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
13 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Mbccop - Gulf Coast
Mobile, Alabama, United States
- Ccop - Colorado Cancer Research Program, Incorporated
Denver, Colorado, United States
- Mbccop - University of Illinois at Chicago
Chicago, Illinois, United States
- Ccop - Central Illinois
Decatur, Illinois, United States
- Ccop - Kalamazoo
Kalamazoo, Michigan, United States
- Ccop - Kansas City
Kansas City, Missouri, United States
- Ccop - Hematology-Oncology Associates of Central New York
East Syracuse, New York, United States
- University of Rochester Cancer Center Ccop Research Base
Rochester, New York, United States
- Ccop - Southeast Cancer Control Consortium
Goldsboro, North Carolina, United States
- Ccop - Columbus
Columbus, Ohio, United States
- Ccop - Dayton
Dayton, Ohio, United States
- Ccop - Greenville
Greenville, South Carolina, United States
- Ccop - Northwest
Tacoma, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Oct 2002
- Primary completion
- 31 Dec 2006
- Completion
- 31 Dec 2006
- Last update posted
- 14 Oct 2015
- Registered enrollment
- 400
- Registry id
- NCT00031837
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.